The Impact of Smoking Cessation Duration on Microvascular Complications in Diabetes
-
By
-
Soonsu Shin
-
Min-Ho Kim
-
Jae-Hong Ryoo
-
October 2, 2026
Clinical Scorecard: The Impact of Smoking Cessation Duration on Microvascular Complications in Diabetes
At a Glance
| Category | Detail |
|---|
| Condition | Diabetes and Microvascular Complications |
| Key Mechanisms | Cigarette smoking elevates risks of diabetic nephropathy, retinopathy, and neuropathy via systemic inflammation and endothelial dysfunction. |
| Target Population | Patients with type 2 diabetes |
| Care Setting | Retrospective cohort study using national health insurance database |
Key Highlights
- Diabetic microvascular complications affect nearly half of people with diabetes.
- Smoking cessation duration may influence the risk of developing microvascular complications.
- Persistent smoking is associated with increased risk of nephropathy and neuropathy.
- The study utilized a large national health insurance database for data collection.
- Cessation duration was categorized into intervals to assess risk reduction.
Guideline-Based Recommendations
Diagnosis
- Use ICD-10 codes to identify diabetic microvascular complications.
Management
- Encourage smoking cessation as a lifestyle modification to reduce complication risks.
Monitoring & Follow-up
- Regular health checkups to assess smoking status and monitor for complications.
Risks
- Increased risk of nephropathy, retinopathy, and neuropathy associated with smoking.
Patient & Prescribing Data
Adults aged 40 years or older diagnosed with type 2 diabetes.
Cessation duration is critical for reducing the risk of microvascular complications.
Clinical Best Practices
- Implement smoking cessation programs for patients with diabetes.
- Monitor patients' smoking status regularly during health checkups.
- Educate patients on the risks of smoking related to diabetic complications.
Related Resources & Content
